JANX
Janux Therapeutics·NASDAQ
--
--(--)
--
--(--)
JANX fundamentals
Janux Therapeutics (JANX) released its earnings on Aug 7, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.55 (YoY -400.00%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.55
-400.00%
Report date
Aug 7, 2025
EPS
Actual | -0.62 | -0.26 | -0.33 | -0.32 | -0.41 | -0.4 | -0.39 | -0.42 | -0.42 | -0.25 | -0.25 | -0.3 | -0.11 | -0.51 | -0.36 | -0.38 | -0.55 |
Forecast | -0.14 | -0.1767 | -0.27 | -0.32 | -0.3167 | -0.4675 | -0.4812 | -0.486 | -0.502 | -0.47 | -0.4152 | -0.3313 | -0.3107 | -0.3273 | -0.4607 | -0.3821 | -0.4723 |
Surprise | -342.86% | -47.14% | -22.22% | 0.00% | -29.46% | +14.44% | +18.95% | +13.58% | +16.33% | +46.81% | +39.79% | +9.45% | +64.60% | -55.82% | +21.86% | +0.55% | -16.45% |
Revenue
Actual | 491.00K | 1.16M | 1.62M | 1.59M | 2.38M | 1.81M | 2.85M | 2.05M | 1.06M | 2.52M | 2.46M | 1.25M | 8.90M | 439.00K | 0 | 0 | 0 |
Forecast | 133.33K | 133.33K | 433.33K | 810.40K | 650.00K | 742.58K | 805.50K | 672.35K | 875.00K | 845.50K | 750.00K | 878.57K | 772.00K | 1.50M | 409.92K | 590.91K | 272.73K |
Surprise | +268.25% | +769.25% | +272.92% | +96.75% | +266.54% | +144.15% | +253.20% | +204.60% | +20.80% | +197.69% | +228.13% | +42.50% | +1052.46% | -70.64% | -100.00% | -100.00% | -100.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Janux Therapeutics's revenue and profit?What is the market's earnings forecast for Janux Therapeutics next quarter?What guidance did Janux Therapeutics's management provide for the next earnings period?What does Janux Therapeutics do and what are its main business segments?What were the key takeaways from Janux Therapeutics's earnings call?Did Janux Therapeutics beat or miss consensus estimates last quarter?What is Janux Therapeutics's gross profit margin?What is Janux Therapeutics's latest dividend and current dividend yield?
